Penserra Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,652
| Closed | -$122K | – | 1272 |
|
|
2022
Q2 | $122K | Buy |
4,652
+1,593
| +52% | +$41.8K | ﹤0.01% | 743 |
|
|
2022
Q1 | $107K | Sell |
3,059
-580
| -16% | -$20.3K | ﹤0.01% | 827 |
|
|
2021
Q4 | $117K | Sell |
3,639
-680
| -16% | -$21.9K | ﹤0.01% | 804 |
|
|
2021
Q3 | $127K | Sell |
4,319
-4,425
| -51% | -$130K | ﹤0.01% | 718 |
|
|
2021
Q2 | $224K | Sell |
8,744
-6,018
| -41% | -$154K | ﹤0.01% | 622 |
|
|
2021
Q1 | $202K | Sell |
14,762
-6,939
| -32% | -$95K | ﹤0.01% | 578 |
|
|
2020
Q4 | $359K | Buy |
+21,701
| New | +$359K | 0.01% | 415 |
|